Open AccessSitagliptin‐induced pancreatitis – a longer road than expected
Author(s) -
Nelson Matthew,
Bhandari Niyati,
Wener Jill
Publication year - 2014
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.83
Subject(s) - sitagliptin , medicine , pancreatitis , regimen , acute pancreatitis , type 2 diabetes , intensive care medicine , diabetes mellitus , gastroenterology , endocrinology
Key Clinical Message Sitagliptin‐induced pancreatitis can occur at any time after the initiation of therapy, even after several years. Patients taking sitagliptin who present with signs and symptoms of mild or severe pancreatitis should immediately discontinue sitagliptin and use an alternate medication regimen for control of type 2 diabetes.